For diabetes devices interoperability is key, and partnerships between Insulet, Dexcom and Abbott show that rival groups see the benefits of working together.
Medtronic has lined up a whole pipeline of new devices – and it will need them.
Heart failure data must repay Bayer and Merck & Co for taking a chance on vericiguat, and a hit for Medtronic’s renal denervation system could erase the shame of its…
Digital health is a core focus for Philips. Might more acquisitions be on the way?
The second half of 2019 saw half as many innovative medical devices approved as the first.
The German start-up must navigate the hazards that have felled other surgical robot developers while simultaneously dealing with a more crowded market.
The market for minimally invasive aortic implants is sewn up – can a tiny private group find a way in?
The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
The speediest device developer is Roche, but a look at companies’ strategies shows the perils of relying on bought-in tech.